Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
2.53B
-
Number of holders
-
3165
-
Total 13F shares, excl. options
-
1.9B
-
Shares change
-
+26.3M
-
Total reported value, excl. options
-
$211B
-
Value change
-
+$3.03B
-
Put/Call ratio
-
0.93
-
Number of buys
-
1360
-
Number of sells
-
-1379
-
Price
-
$110.95
Significant Holders of Merck & Co., Inc. - Common Stock (MRK) as of Q4 2022
3,387 filings reported holding MRK - Merck & Co., Inc. - Common Stock as of Q4 2022.
Merck & Co., Inc. - Common Stock (MRK) has 3,165 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.9B shares
of 2.53B outstanding shares and own 75.26% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (227M shares), BlackRock Inc. (215M shares), STATE STREET CORP (118M shares), WELLINGTON MANAGEMENT GROUP LLP (62M shares), GEODE CAPITAL MANAGEMENT, LLC (48.3M shares), MORGAN STANLEY (41.9M shares), BANK OF AMERICA CORP /DE/ (40.2M shares), Bank of New York Mellon Corp (30.4M shares), NORTHERN TRUST CORP (30.2M shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (30M shares).
This table shows the top 3165 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.